Viewing data from:

CALCIBIND

NDA

CELLULOSE SODIUM PHOSPHATE | N018757 | MISSION PHARMACAL CO

2 strengths0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

22 trials from ClinicalTrials.gov — 12 recruiting, 6 completed

Trial	Phase	Status	Sponsor	Enrollment	Dates
Effects of Cistanche Supplementation on Anaerobic Exercise Performance and Recovery in Men With Different Athletic Training Levels NCT07546513	N/A	Not Yet Recruiting	Beijing Sport University	56	2026-06-25 → 2026-09-15
A Safety Trial to Evaluate an Orally Ingested Yeast Modified to Express a Tetra-specific Anti-toxin for Clostridioides Difficile NCT07649096	Phase 1	Not Yet Recruiting	National Institute of Allergy and Infectious Diseases (NIAID)	86	2026-06-15 → 2028-09-22
Evaluation of AppleX™ Apple Extract on Anti-Inflammatory and Healthy Aging Effects NCT07678346	N/A	Not Yet Recruiting	Nutraland USA, Inc.	70	2026-07 → 2027-02
Effect of ZenRest™ Lotus Seed & Rice Germ Extract Blend on Sleep Quality in Menopausal Women NCT07678359	N/A	Not Yet Recruiting	Nutraland USA, Inc.	60	2026-07 → 2026-10
Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia NCT07662330	N/A	Recruiting	Shanghai 10th People's Hospital	50	2026-01-01 → 2027-01-31
Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease NCT07676084	Phase 4	Recruiting	Andover Research Eye Institute	60	2026-06-03 → 2026-12
Tract Closure in PCNL NCT07668817	N/A	Recruiting	Icahn School of Medicine at Mount Sinai	92	2026-07 → 2028-06
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery NCT06664775	Phase 3	Recruiting	Corza Medical GmbH	116	2025-04-02 → 2026-12-31
Effects of Miricell Supplementation on Biomarkers of Healthy Aging and Autophagy NCT07675200	N/A	Recruiting	Nutraland USA, Inc.	70	2026-01-09 → 2026-09
Autophagy-Enhancers to Reduce Sleep Disturbances NCT07383311	N/A	Recruiting	University Medicine Greifswald	76	2025-10-28 → 2029-05

Source: ClinicalTrials.gov. Trials matched by ingredient name.

Products (2)

Sort:

#002 — 2.5GM/PACKET

0 patents0 exclusivities▴

POWDER;ORAL | Approved: Dec 28, 1982

No patent or exclusivity listings for this strength.

#003 — 300GM/BOT

0 patents0 exclusivities▾

POWDER;ORAL | Approved: Oct 16, 1984